From prion diseases to Alzheimer’s disease

  • K. K. Hsiao
Conference paper


Recent advances in the transgenetics of prion diseases and Alzheimer’s disease have led to a clearer understanding of the relationship between these two diseases and the pathogenic mechanisms underlying the two disorders. Earlier studies of transgenic mice expressing prion protein (PrP) underscored the importance of PrP levels and PrP primary structure on the resultant phenotype. Three major parameters influencing the phenotypes of mice expressing the Alzheimer amyloid precursor protein (APP) have also been identified: 1) APP levels; 2) APP primary structure; and 3) mouse host strain. The effects and implications of these parameters in transgenic mice expressing APP are discussed.


Amyloid Precursor Protein Prion Protein Prion Disease Bovine Spongiform Encephalopathy Fatal Familial Insomnia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Brown P, Goldfarb LG, McCombie WR, Nieto A, Squillacote D, Sheremata W, Little BW, Godec MS, Gibbs CJJ, Gajdusek DC (1992) Atypical Creutzfeldt-Jakob disease in an American family with an insert mutation in the PRNP amyloid precursor gene. Neurology 42: 422–7PubMedGoogle Scholar
  2. Brown P, Gibbs CJJ, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC (1994) Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35: 513–529PubMedCrossRefGoogle Scholar
  3. Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577–582PubMedCrossRefGoogle Scholar
  4. Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73: 1339–1347PubMedCrossRefGoogle Scholar
  5. Buxbaum JD, Christensen JL, Ruefli AA, Greengard P, Loring JF (1993) Expression of APP in brains of transgenic mice containing the entire human APP gene. Biochem Biophys Res Commun 197: 639–645PubMedCrossRefGoogle Scholar
  6. Cai X-D, Golde TE, Younkin SG (1993) Release of excess amyloid ß protein from a mutant amyloid ß protein precursor. Science 259: 514–516PubMedCrossRefGoogle Scholar
  7. Chartier-Harlin M-C, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M (1991) Early-onset Alzheimer’s disease caused by mutations at codon 717 of the ß-amyloid precursor protein gene. Nature 353: 844–846PubMedCrossRefGoogle Scholar
  8. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer’s disease increases beta-protein production. Nature 360: 672–674PubMedCrossRefGoogle Scholar
  9. Collinge J, Owen F, Poulter M, Leach M, Crow TJ, Rossor MN, Hardy J, Mullan MJ, Janota I, Lantos PL (1990) Prion dementia without characteristic pathology. Lancet 336: 7–9PubMedCrossRefGoogle Scholar
  10. Collinge J, Whittington MA, Sidle KCL, Smith CJ, Palmer MS, Clarke AR, Jefferys JGR (1994) Prion protein is necessary for normal synaptic function. Nature 370: 295–297PubMedCrossRefGoogle Scholar
  11. Games D, Adams D, Alessandrini R, Barbour R, Berthelotte P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagoplan S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburh I, Little S, Masilah E, McConlogue L, Montoya-Zavaia M, Mucke L, Paganini L, Penalman E, Power M, Schenk D, Peubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimertype neuropathology in transgenic mice overexpressing V717F ß-amyloid precursor protein. Nature 373: 523–527PubMedCrossRefGoogle Scholar
  12. Goate A, Chartier-Harlin MA, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vances M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349: 704–706PubMedCrossRefGoogle Scholar
  13. Hendriks L, Duijn CMv, Cras P, Cruts M, Hul WV, Harskamp F v, Warren A, McInnis MG, Antonarakis SE, Martin J-J, Hofman A, Broeckhoven CV (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the ß-amyloid precursor protein gene. Nature Genet 1: 218–221PubMedCrossRefGoogle Scholar
  14. Higgins LS, Holtzman DM, Rabin J, Mobley WC, Cordell B (1994) Transgenic mouse brain histopathology resembles early Alzheimer’s disease. Ann Neurol 35: 598–607PubMedCrossRefGoogle Scholar
  15. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Westaway D, Ott J, Prusiner SB (1989) Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338: 342–345PubMedCrossRefGoogle Scholar
  16. Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250:1587–1590PubMedCrossRefGoogle Scholar
  17. Hsiao KK, Groth D, Scott M, Yang S-L, Serban H, Rapp D, Foster D, Torchia M, DeArmond SJ, Prusiner SB (1994) Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci 91: 9126–9130PubMedCrossRefGoogle Scholar
  18. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D, Iadecola C, Clark HB, Carlson G (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15: 1203–1218PubMedCrossRefGoogle Scholar
  19. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Youmkin S, Yang F, Cole G (1996) Correlative memory deficits, Aß elevation, and amyloid plagues in transgenic miceGoogle Scholar
  20. Kammesheidt A, Boyce FM, Spanoyannis AF, Cummings BJ, Ortegon M, Cotman C, Vaught JL, Neve RL (1992) Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci USA 89: 10857–10861PubMedCrossRefGoogle Scholar
  21. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond G J, Lansbury PT, Caughey B (1994) Cell-free formation of protease-resistant prion protein. Nature 370: 471–474PubMedCrossRefGoogle Scholar
  22. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G (1995) The Alzheimer’s Aß peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet 9: 21–30PubMedCrossRefGoogle Scholar
  23. Lamb BT, Sisodia SS, Lawler AM, Slunt HH, Kitt CA, Kearns WG, Pearson PL, Price DL, Gearhart JD (1993) Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature Genet 5: 22–30PubMedCrossRefGoogle Scholar
  24. Medori R, Montagna P, Tritschler HJ, LeBlanc A, Cortelli P, Tinuper P, Lugaresi E, Gambetti P (1992) Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology 42: 669–670PubMedGoogle Scholar
  25. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L (1992) A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of ß-amyloid. Nature Genet 1: 345–347PubMedCrossRefGoogle Scholar
  26. Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 254: 97–99PubMedCrossRefGoogle Scholar
  27. Oesch B, Westaway D, Wälchli M, McKinley MP, Kent SBH, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE, Prusiner SB, Weissmann C (1985) A cellular gene encodes scrapie PrP 27-30 protein. Cell 40: 735–746PubMedCrossRefGoogle Scholar
  28. Pan K-M, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, Prusiner SB (1993) Conversion of a-helices into ß-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci 90:10962–10966PubMedCrossRefGoogle Scholar
  29. Pearson BE, Choi TK (1993) Expression of the human ß-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice. Proc Natl Acad Sci USA 90: 10578–10582PubMedCrossRefGoogle Scholar
  30. Price DL, Borchelt DR, Walker LC, Sisodia SS (1992) Toxicity of synthetic Aß peptides and modeling of Alzheimer’s disease. Neurobiol Aging 13: 623–625PubMedCrossRefGoogle Scholar
  31. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136–144PubMedCrossRefGoogle Scholar
  32. Prusiner SB (1985) Scrapie prions, brain amyloid, and senile dementia. Curr Top Cell Regul 26: 79–95PubMedGoogle Scholar
  33. Prusiner SB (1992) Chemistry and biology of prions. Biochemistry 31: 12277–12288PubMedCrossRefGoogle Scholar
  34. Prusiner SB, Hsiao KK (1994) Human prion diseases. Ann Neurol 35: 385–395PubMedCrossRefGoogle Scholar
  35. Prusiner SB, Scott M, Foster D, Pan KM, Groth D, Mirenda C, Torchia M, Yang SL, Serban D, Carlson GA, Hoppe PC, Westaway D, DeArmond SJ (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63: 673–686PubMedCrossRefGoogle Scholar
  36. Quon D, Wang Y, Catalano R, Scardina JM, Murakami K, Cordeil B (1991) Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature 352: 239–41PubMedCrossRefGoogle Scholar
  37. Sandhu FA, Salim M, Zain SB (1991) Expression of the human ß-amyloid protein of Alzheimer’s disease specifically in the brains of transgenic mice. J Biol Chem 266: 21331–21334PubMedGoogle Scholar
  38. Scott M, Foster D, Mirenda C, Serban D, Coufal F, Wälchli M, Torchia M, Groth D, Carlson G, DeArmond SJ, Westaway D, Prusiner SB (1989) Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59: 847–857PubMedCrossRefGoogle Scholar
  39. Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, Burlingame AL, Prusiner SB (1993) Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32: 1991–2002PubMedCrossRefGoogle Scholar
  40. Suzuki N, Cheung TT, Cai XD, Okada A, Lotvos J, Eckman C, Golde TE, Younkin SG (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264: 1335–1340Google Scholar
  41. Tateishi J, Doh-ura K, Kitamoto T, Tranchant C, Steinmetz G, Warter JM, Boellaard JW (1992) Prion protein gene analysis and transmission studies of Creutzfeldt-Jakob disease. In: Prusiner SB, Collinge J, Powell J, Anderton B (eds) Prion diseases of humans and animals. Ellis Horwood, London, pp 129–138Google Scholar
  42. Westaway D, DeArmond SJ, Cayetano-Canias J, Groth D, Foster D, Yang S-L, Torchia M, Carlson GA, Prusiner SB (1994) Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic ice overexpressing wild-type prion proteins. Cell 76: 117–129PubMedCrossRefGoogle Scholar
  43. Yamaguchi F, Richards SJ, Beyreuther K, Salbaum M, Carlson GA, Dunnett SB (1991) Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. Neuroreport 2: 781–784PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1997

Authors and Affiliations

  • K. K. Hsiao
    • 1
  1. 1.Department of NeurologyUniversity of MinnesotaMinneapolisUSA

Personalised recommendations